Test set bias affects reproducibility of gene signatures

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Bioinform.

• Publication date

  2015-07-15

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1093/bioinformatics/btv157PMID 25788628PMCID PMC4495301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Removing batch effects for prediction problems with frozen surrogate variable analysis

  2013cited by this paper
• A single-sample microarray normalization method to facilitate personalized-medicine workflows.

  2012cited by this paper
• NCBI GEO: archive for functional genomics data sets—update

  2012cited by this paper
• A three-gene model to robustly identify breast cancer molecular subtypes.

  2012cited by this paper
• Taming the dragon: genomic biomarkers to individualize the treatment of cancer

  2011cited by this paper
• Frozen robust multiarray analysis (fRMA).

  2010cited by this paper
• Genetic signatures of exceptional longevity in humans.

  2010cited by this paper
• Supervised risk predictor of breast cancer based on intrinsic subtypes.

  2009cited by this paper
• aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory

  2008cited by this paper
• Challenges in projecting clustering results across gene expression-profiling datasets.

  2007cited by this paper
• ArrayExpress—a public database of microarray experiments and gene expression profiles

  2006cited by this paper
• Converting a breast cancer microarray signature into a high-throughput diagnostic test

  2006cited by this paper
• Microarray data analysis: from disarray to consolidation and consensus

  2006cited by this paper
• BMC Genomics BioMed Central Methodology article

  2005cited by this paper
• Prediction of cancer outcome with microarrays: a multiple random validation strategy.

  2005cited by this paper
• Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer.

  2005cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments

  year unknowncited by this paper

• DeCAF defines clinical fibroblast subtypes and multidimensional tumor-stroma crosstalk shaping prognosis and immunotherapy response.

  2026cites this paper
• Exploring the influence of pre-analytical variables on gene expression measurements and relative expression orderings in cancer research

  2025cites this paper
• Individualized diagnosis of rheumatoid arthritis: A rank-based qualitative T cell-related signature

  2025cites this paper
• Personalized risk stratification in colorectal cancer via PIANOS system

  2025influential citation
• Accelerating battery innovation: AI-powered molecular discovery.

  2025cites this paper
• Analysis of the cross-study replicability of tuberculosis gene signatures using 49 curated human transcriptomic datasets.

  2025cites this paper
• Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes

  2024cites this paper
• Thinking points for effective batch correction on biomedical data

  2024cites this paper
• Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial

  2024cites this paper
• Ten quick tips for ensuring machine learning model validity

  2024cites this paper
• Comparison of gene set scoring methods for reproducible evaluation of tuberculosis gene signatures

  2024cites this paper
• Ensemble methods of rank-based trees for single sample classification with gene expression profiles

  2024cites this paper
• Comparison of gene set scoring methods for reproducible evaluation of multiple tuberculosis gene signatures

  2023cites this paper
• Low CDKN1B Expression Associated with Reduced CD8+ T Lymphocytes Predicts Poor Outcome in Breast Cancer in a Machine Learning Analysis

  2023cites this paper
• Multi-source domain adaptation for regression

  2023cites this paper
• Analysis of the Cross-Study Replicability of Tuberculosis Gene Signatures Using 49 Curated Transcriptomic Datasets

  2023cites this paper
• Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas

  2023cites this paper
• Annotated Compendium of 102 Breast Cancer Gene-Expression Datasets

  2023cites this paper
• TimiGP: Inferring cell-cell interactions and prognostic associations in the tumor immune microenvironment through gene pairs

  2023cites this paper
• Building flexible and robust analysis frameworks for molecular subtyping of cancers

  2023cites this paper
• Normalization of Large-Scale Transcriptome Data Using Heuristic Methods

  2023cites this paper
• Heuristic normalization procedure for batch effect correction

  2023cites this paper
• A Simple Method for Robust and Accurate Intrinsic Subtyping of Breast Cancer

  2023cites this paper
• On data normalization and batch-effect correction for tumor subtyping with microRNA data

  2023cites this paper
• Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma

  2022cites this paper
• TimiGP: inferring inter-cell functional interactions and clinical values in the tumor immune microenvironment through gene pairs

  2022cites this paper
• Prioritizing prognostic-associated subpopulations and individualized recurrence risk signatures from single-cell transcriptomes of colorectal cancer

  2022cites this paper
• The Current Staging and Classification Systems of Breast Cancer and Their Pitfalls: Is It Possible to Integrate the Complexity of this Neoplasm into a Unified Staging System?

  2022cites this paper
• Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival

  2021cites this paper
• Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models

  2021cites this paper
• A gradient tree boosting and network propagation derived pan-cancer survival network of the tumor microenvironment

  2021cites this paper
• Gene Network Analysis of Hepatocellular Carcinoma Identifies Modules Associated with Disease Progression, Survival, and Chemo Drug Resistance

  2021cites this paper
• Agent Clustering Strategy Based on Metabolic Flux Distribution and Transcriptome Expression for Novel Drug Development

  2021cites this paper
• A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level

  2021cites this paper
• Protein structure–based gene expression signatures

  2021influential citation
• Analyzing biomarker discovery: Estimating the reproducibility of biomarker sets

  2021cites this paper
• A Cancer-Specific Qualitative Method for Estimating the Proportion of Tumor-Infiltrating Immune Cells

  2021cites this paper
• A novel immune prognostic index for stratification of high-risk patients with early breast cancer

  2021cites this paper
• Cross-validation approaches for multi-study predictions

  2020cites this paper
• A gene expression‐based single sample predictor of lung adenocarcinoma molecular subtype and prognosis

  2020cites this paper
• Galgo: a bi-objective evolutionary meta-heuristic identifies robust transcriptomic classifiers associated with patient outcome across multiple cancer types

  2020cites this paper
• Development and verification of a personalized immune prognostic feature in breast cancer

  2020cites this paper
• Distinguishing Kawasaki Disease from Febrile Infectious Disease Using Gene Pair Signatures

  2020cites this paper
• Protein structure-based gene expression signatures

  2020cites this paper
• An absolute human stemness index associated with oncogenic dedifferentiation

  2020cites this paper
• An Improved, Assay Platform Agnostic, Absolute Single Sample Breast Cancer Subtype Classifier

  2020cites this paper
• A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy

  2020cites this paper
• The Prostate

  2020cites this paper
• OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts

  2019cites this paper
• Turning straw into gold: building robustness into gene signature inference.

  2019cites this paper
• Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer

  2019cites this paper
• Development of prognostic signature and nomogram for patients with breast cancer

  2019cites this paper
• Modeling Between-Study Heterogeneity for Improved Replicability in Gene Signature Selection and Clinical Prediction

  2019influential citation
• Intratumor Heterogeneity

  2019cites this paper
• HealthPolicy 7-3-2018 Consensus on Molecular Subtypes of High-grade Serous Ovarian Carcinoma

  2019cites this paper
• A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection

  2019cites this paper
• Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer

  2019cites this paper
• A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients

  2019cites this paper
• Accurate modeling of replication rates in genome-wide association studies by accounting for Winner’s Curse and study-specific heterogeneity

  2019cites this paper
• Annexin A7 is correlated with better clinical outcomes of patients with breast cancer

  2018cites this paper
• A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers.

  2018cites this paper
• Expression of Fibroblast Growth Factor 5 (FGF5) and Its Influence on Survival of Breast Cancer Patients

  2018cites this paper
• Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer

  2018cites this paper
• Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinoma

  2018cites this paper
• Improving the ACGIH threshold limit value (TLV) process

  2018cites this paper
• Training replicable predictors in multiple studies

  2018cites this paper
• PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts

  2018cites this paper
• A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings

  2018cites this paper
• CytoPred: 7-gene pair metric for AML cytogenetic risk prediction

  2018cites this paper
• The expression of ubiquitin‐specific peptidase 8 and its prognostic role in patients with breast cancer

  2018cites this paper
• Revisiting Connectivity Map from a gene co-expression network analysis

  2018cites this paper
• Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma

  2018cites this paper
• A qualitative transcriptional signature to reclassify estrogen receptor status of breast cancer patients

  2018cites this paper
• Alternative empirical Bayes models for adjusting for batch effects in genomic studies

  2018cites this paper
• Identification of gene pairs through penalized regression subject to constraints

  2017cites this paper
• Watching the clock for 25 years in FlyClockbase: Variability in circadian clocks of Drosophila melanogaster as uncovered by biological model curation

  2017cites this paper
• Identification of Acquired Molecular Dependencies in Advanced Breast and Ovarian Cancers

  2017cites this paper
• Can Peripheral Blood-Derived Gene Expressions Characterize Individuals at Ultra-high Risk for Psychosis?

  2017cites this paper
• Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer

  2017cites this paper
• The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB

  2017cites this paper
• Gene network inherent in genomic big data improves the accuracy of prognostic prediction for cancer patients

  2017cites this paper
• Ror2 Signaling and Its Relevance in Breast Cancer Progression

  2017cites this paper
• Modeling Between-Study Heterogeneity for Improved Reproducibility in Gene Signature Selection and Clinical Prediction

  2017influential citation
• Protein complex-based analysis is resistant to the obfuscating consequences of batch effects --- a case study in clinical proteomics

  2017cites this paper
• Rank-based Molecular Prognosis and Network-guided Biomarker Discovery for Breast Cancer. (Pronostic moléculaire basé sur l'ordre des gènes et découverte de biomarqueurs guidé par des réseaux pour le cancer du sein)

  2017cites this paper
• Feature selection in clinical proteomics: with great power comes great reproducibility.

  2017cites this paper
• Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers

  2017cites this paper
• Exome-capture RNA-sequencing of decade-old breast cancers and matched decalcified bone metastases identifies clinically actionable targets

  2017cites this paper
• Consensus on Molecular Subtypes of Ovarian Cancer

  2017cites this paper
• Evaluating hepatocellular carcinoma cell lines for tumour samples using within‐sample relative expression orderings of genes

  2017cites this paper
• Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction

  2016cites this paper
• Evaluating feature-selection stability in next-generation proteomics

  2016cites this paper
• Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy

  2016cites this paper
• Rank-based classifiers for extremely high-dimensional gene expression data

  2016cites this paper
• An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

  2016cites this paper
• Design principles for clinical network-based proteomics.

  2016cites this paper
• Assessing Reproducibility and Value in Genomic Signatures

  2016cites this paper
• Pathway and network analyses in context of Wnt signaling in breast cancer

  2016cites this paper
• Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer

  2015cites this paper
• Overcoming analytical reliability issues in clinical proteomics using rank-based network approaches

  2015cites this paper